Clinical trial
Alpha-synuclein Level in the Saliva as a Potential Diagnostic Aid to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome
NCT03156647 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha-synuclein Level in the Saliva as a Potential Diagnostic Aid to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2017
- Completion date
- July 16, 2020
- Enrollment
- 80 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.